ALKBH5 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.288200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.946000E-01
Normal-vs-Stage2
7.422000E-01
Normal-vs-Stage3
1.618020E-01
Normal-vs-Stage4
5.573400E-01
Stage1-vs-Stage2
1.815580E-01
Stage1-vs-Stage3
2.553400E-01
Stage1-vs-Stage4
4.303400E-01
Stage2-vs-Stage3
3.321000E-01
Stage2-vs-Stage4
7.130000E-01
Stage3-vs-Stage4
6.325800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.662400E-01
Normal-vs-AfricanAmerican
6.868800E-01
Normal-vs-Asian
2.189200E-01
Caucasian-vs-AfricanAmerican
6.911200E-01
Caucasian-vs-Asian
5.003600E-02
AfricanAmerican-vs-Asian
2.285000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.089600E-01
Normal-vs-Female
9.471200E-01
Male-vs-Female
2.560200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.915800E-01
Normal-vs-Age(41-60Yrs)
2.228000E-01
Normal-vs-Age(61-80Yrs)
5.835800E-01
Normal-vs-Age(81-100Yrs)
5.580800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.438400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.836400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.958400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.519800E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.342000E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.283600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.087600E-01
Normal-vs-Daily Drinker
9.749000E-01
Normal-vs-Weekly Drinker
9.472400E-01
Normal-vs-Occasional Drinker
9.074200E-01
Normal-vs-Social Drinker
5.390400E-01
Non Drinker-vs-Daily Drinker
2.664200E-01
Non Drinker-vs-Weekly Drinker
1.518370E-01
Non Drinker-vs-Occasional Drinker
1.252240E-01
Non Drinker-vs-Social Drinker
1.676590E-01
Daily Drinker-vs-Weekly Drinker
9.139400E-01
Daily Drinker-vs-Occasional Drinker
8.643400E-01
Daily Drinker-vs-Social Drinker
6.116000E-01
Weekly Drinker-vs-Occasional Drinker
9.371800E-01
Weekly Drinker-vs-Social Drinker
5.262400E-01
Occasional Drinker-vs-Social Drinker
4.886600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.037400E-01
Normal-vs-Grade 2
8.956000E-01
Normal-vs-Grade 3
8.662000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.974300E-02
Grade 1-vs-Grade 3
4.183600E-02
Grade 1-vs-Grade 4
8.037400E-01
Grade 2-vs-Grade 3
3.486000E-01
Grade 2-vs-Grade 4
8.956000E-01
Grade 3-vs-Grade 4
8.662000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.263600E-01
Normal-vs-NonDiabetic
9.510000E-01
Diabetic-vs-NonDiabetic
6.146000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.893000E-01
Normal-vs-NoPancreatitis
8.626800E-01
Pancreatitis-vs-NoPancreatitis
9.129200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.258800E-01
Normal-vs-N1
8.015600E-01
N0-vs-N1
4.646800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.329400E-01
Normal-vs-TP53-NonMutant
3.144200E-01
TP53-Mutant-vs-TP53-NonMutant
1.078520E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
